1 April 2025

Last updated: Sunday 30 March 2025

Research Directory

Novel oncology drugs approved in a year of change

Progressive increase in oncology drug approvals

Checkpoint inhibitors are focus at ESMO

ASCO delivers new cancer data - and one surprise

Oncology Review: A positive trajectory for approvals

Oncology drug approvals rise, with help from China

Checkpoint Inhibitors: A decade of innovation

ESMO 2021: Oncology developers present their findings

Oncology approvals rise, driven by novel compounds

Drug development robust, despite the pandemic